Skip to main content
Premium Trial:

Request an Annual Quote

Whitehead Licenses Reverse Transfection Patent Rights to Corning

NEW YORK, Aug. 3 (GenomeWeb News) - The Whitehead Institute for Biomedical Research has granted Corning Life Sciences a license for the patent rights to its reverse transfection technology, Corning said yesterday.

 

Corningwill pair the microarray-based method for the functional analysis in mammalian cells of many genes in parallel with other technology to enhance its molecular and cell culture applications.

 

A spokesperson for the Whitehead said the technology could be useful in drug screening and development, though a representative from Corning declined to comment on possible future applications.

 

Financial details were not discussed.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more